AMSBIO have introducedÂ a new range of proprietary reagents designed for researchersÂ investigating targeted cancer therapy. Targeted cancer therapyÂ represents a promising new cancer treatment, one which delivers drugs in specific carriers and interferes with the specific target molecules that play a critical role in tumour growth and progression. Exosomes expressing specific surface markers (among them CD81, CD63, […]
November 29, 2023 6:34 pm
October 17, 2023 6:31 pm
September 21, 2023 3:24 pm
Your Data and Privacy
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.